All Stories

  1. A Novel Combinatorial Regimen Using Sorafenib and Uttroside B, A US FDA-designated ‘Orphan Drug’, for the Treatment of Hepatocellular Carcinoma

    Article • Anti-Cancer Agents in Medicinal Chemistry, November 2024, Bentham Science Publishers

    Dr Kuzhuvelil B Harikumar, Induja DK